| Trigger for group A streptococcal M1T1 invasive disease JN Cole, JD McArthur, FC McKay, ML Sanderson-Smith, AJ Cork, ... The FASEB journal 20 (10), 1745-1747, 2006 | 190 | 2006 |
| The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis KS Gandhi, FC McKay, M Cox, C Riveros, N Armstrong, RN Heard, ... Human molecular genetics 19 (11), 2134-2143, 2010 | 150 | 2010 |
| Is plasminogen deployed as a Streptococcus pyogenes virulence factor? MJ Walker, JD McArthur, F McKay, M Ranson TRENDS in Microbiology 13 (7), 308-313, 2005 | 143 | 2005 |
| Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model RK Sheean, FC McKay, E Cretney, CR Bye, ND Perera, D Tomas, ... JAMA neurology 75 (6), 681-689, 2018 | 141 | 2018 |
| Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection FC McKay, JD McArthur, ML Sanderson-Smith, S Gardam, BJ Currie, ... Infection and immunity 72 (1), 364-370, 2004 | 100 | 2004 |
| Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation. JD McArthur, FC McKay, V Ramachandran, P Shyam, AJ Cork, ... | 86 | 2008 |
| Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis FC McKay, LI Swain, SD Schibeci, JP Rubio, TJ Kilpatrick, RN Heard, ... Genes & Immunity 9 (1), 1-6, 2008 | 85 | 2008 |
| Functionally significant differences in expression of disease-associated IL-7 receptor α haplotypes in CD4 T cells and dendritic cells E Hoe, FC McKay, SD Schibeci, K Gandhi, RN Heard, GJ Stewart, ... The Journal of Immunology 184 (5), 2512-2517, 2010 | 70 | 2010 |
| The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease GP Parnell, PN Gatt, M Krupa, D Nickles, FC McKay, SD Schibeci, ... Clinical immunology 151 (1), 16-24, 2014 | 65 | 2014 |
| A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis C Riveros, D Mellor, KS Gandhi, FC McKay, MB Cox, R Berretta, ... PLoS One 5 (12), e14176, 2010 | 63 | 2010 |
| A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis C Riveros, D Mellor, KS Gandhi, FC McKay, MB Cox, R Berretta, ... PLoS One 5 (12), e14176, 2010 | 63 | 2010 |
| The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells F Shahijanian, GP Parnell, FC McKay, PN Gatt, M Shojoei, KS O'Connor, ... Human molecular genetics 23 (6), 1425-1434, 2014 | 51 | 2014 |
| Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: a comparison of three methods in a large Australasian cohort F McKay, S Schibeci, R Heard, G Stewart, D Booth Journal of immunological methods 310 (1-2), 20-29, 2006 | 49 | 2006 |
| Parameters governing invasive disease propensity of non-M1 serotype group A streptococci PG Maamary, ML Sanderson-Smith, RK Aziz, A Hollands, JN Cole, ... Journal of innate immunity 2 (6), 596-606, 2010 | 45 | 2010 |
| Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility A Afrasiabi, GP Parnell, N Fewings, SD Schibeci, MA Basuki, ... Genome medicine 11, 1-13, 2019 | 42 | 2019 |
| The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function J Field, F Shahijanian, S Schibeci, ... PloS one 10 (6), e0127080, 2015 | 38 | 2015 |
| CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis FC McKay, LI Swain, SD Schibeci, JP Rubio, TJ Kilpatrick, RN Heard, ... Journal of autoimmunity 31 (1), 52-58, 2008 | 37 | 2008 |
| The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis NL Fewings, PN Gatt, FC McKay, GP Parnell, SD Schibeci, J Edwards, ... Journal of autoimmunity 78, 57-69, 2017 | 36 | 2017 |
| BAFF is a biological response marker to IFN-β treatment in multiple sclerosis KS Gandhi, FC McKay, SD Schibeci, JW Arthur, RN Heard, GJ Stewart, ... Journal of Interferon & Cytokine Research 28 (9), 529-540, 2008 | 33 | 2008 |
| Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study S Mahurkar, M Moldovan, V Suppiah, M Sorosina, F Clarelli, G Liberatore, ... The pharmacogenomics journal 17 (4), 312-318, 2017 | 29 | 2017 |
